Valued at $135.5M at its early-stage round, Dec 2025. Nothing has traded since.
- ·The complete investor list: 38 names
- ·Watch GEn1E Lifesciences: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
GEn1E Lifesciences funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $5.5M | ▮ | ▮ |
| Dec 2022 | Early Stage VC | $17.0M | ▮ | ▮ |
Membership and data by Private Market View
GEn1E Lifesciences valuation
GEn1E Lifesciences was valued at $136 million at its early-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has GEn1E Lifesciences raised?
GEn1E Lifesciences has raised $25.6 million across 2 recorded rounds since 2022. The largest was a $5.5 million early-stage round in Oct 2025.
GEn1E Lifesciences has filed 1 Form D with the SEC, most recently in Dec 2022 ($17 million sold to 89 investors).
How GEn1E Lifesciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For GEn1E Lifesciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about GEn1E Lifesciences
- What is GEn1E Lifesciences worth?
- GEn1E Lifesciences is valued at $135.5M as of Oct 2026. Valued at $135.5M at its early-stage round, Dec 2025. Nothing has traded since.
- How much has GEn1E Lifesciences raised?
- GEn1E Lifesciences has raised $25.6M in total funding across 2 recorded rounds.
- When did GEn1E Lifesciences last raise?
- GEn1E Lifesciences last raised in Oct 2025 (Early Stage VC), raising $5.5M.